MediXall Group, Inc.
MDXL
$0.00
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 129.05% | 50.39% | 60.16% | 18.40% | 16.22% |
| Total Depreciation and Amortization | -38.46% | -30.77% | -75.56% | -20.23% | 161.90% |
| Total Amortization of Deferred Charges | -100.00% | -84.27% | -83.84% | -93.62% | 19.11% |
| Total Other Non-Cash Items | -243.91% | -- | -- | -84.17% | 292.83% |
| Change in Net Operating Assets | -89.88% | 35.32% | -30.92% | 872.90% | -70.63% |
| Cash from Operations | -50.70% | 6.84% | 31.12% | 66.34% | 70.61% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -43.84% | -17.80% | -20.99% | -60.10% | -68.05% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 55.69% | -17.80% | -21.31% | -61.61% | -68.05% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 92.13% | -230.06% | 4,018.18% | 101.52% | 90.95% |